Diane Re is an assistant professor of environmental health sciences at the Columbia University School of Public Health. Re’s research team focuses on unraveling the environmental triggers and gene-environment interactions that lead to adult-onset neurodegenerative diseases, such as ALS and Parkinson’s disease.

Shane Liddelow is an assistant professor in the Department of Neuroscience and Physiology at the NYU Grossman School of Medicine. Liddelow’s basic research focuses on the role of non-neuronal cells in neuroinflammation that leads to neurodegeneration in diseases such as Alzheimer’s disease and ALS.

Clotilde Lagier-Tourenne is an associate professor of neurology at the Massachusetts General Institute for Neurodegeneration. Lagier-Tourenne’s lab focuses on basic science and uses a combination of genomic approaches across multiple model systems (animal models, neurons from patients, and post-mortem tissue) to identify mechanisms underlying ALS and frontotemporal dementia.

Steve Finkbeiner is director of the Center for Systems and Therapeutics and the Taube/Koret Center for Neurodegenerative Disease Research at Gladstone Institutes. Finkbeiner’s research is broadly focused across many neurodegenerative and psychiatric diseases.

Lucie Bruijn serves as the therapeutic area biomarker lead for amyotrophic lateral sclerosis (ALS) at Novartis UK.